Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Downregulation of TNF receptor-associated protein-2/p97 in renal cell carcinoma.

Stassar MJ, Pitzer C, Zøller M.

Oncol Res. 1999;11(2):85-90.

PMID:
10489164
2.
3.

Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.

Struckmann K, Schraml P, Simon R, Elmenhorst K, Mirlacher M, Kononen J, Moch H.

Cancer Res. 2004 Mar 1;64(5):1632-8.

4.

Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.

Yamauchi M, Kataoka H, Itoh H, Seguchi T, Hasui Y, Osada Y.

J Urol. 2004 Feb;171(2 Pt 1):890-6.

PMID:
14713848
5.

Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.

Cheung C, Vesey D, Cotterill A, Douglas M, Gobe G, Nicol D, Johnson D.

Int J Urol. 2005 Jan;12(1):17-28.

6.
7.
8.

Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

Tölle A, Jung M, Lein M, Johannsen M, Miller K, Moch H, Jung K, Kristiansen G.

BMC Cancer. 2009 Jul 21;9:248. doi: 10.1186/1471-2407-9-248.

9.
10.

Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.

Iwai A, Fujii Y, Kawakami S, Takazawa R, Kageyama Y, Yoshida MA, Kihara K.

Mol Cell Endocrinol. 2004 Oct 29;226(1-2):11-7.

PMID:
15489000
11.

Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies.

Grabmaier K, de Weijert M, Uemura H, Schalken J, Oosterwijk E.

Urology. 2002 Aug;60(2):357-62.

PMID:
12137853
12.

Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.

Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD.

Cancer Res. 2002 Jun 1;62(11):3093-9.

13.

Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.

Yuan J, Takahashi A, Masumori N, Itoh N, Tsukamoto T.

Int J Urol. 2006 Mar;13(3):265-70.

14.

Clinical significance of ST3Gal IV expression in human renal cell carcinoma.

Saito S, Yamashita S, Endoh M, Yamato T, Hoshi S, Ohyama C, Watanabe R, Ito A, Satoh M, Wada T, Paulson JC, Arai Y, Miyagi T.

Oncol Rep. 2002 Nov-Dec;9(6):1251-5.

PMID:
12375029
15.

BIGH3 is overexpressed in clear cell renal cell carcinoma.

Yamanaka M, Kimura F, Kagata Y, Kondoh N, Asano T, Yamamoto M, Hayakawa M.

Oncol Rep. 2008 Apr;19(4):865-74.

PMID:
18357369
16.

Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.

17.

The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.

Hemmerlein B, Johanns U, Halbfass J, Böttcher T, Heuser M, Radzun HJ, Thelen P.

Int J Oncol. 2004 May;24(5):1069-76.

PMID:
15067327
18.
19.

Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.

Wethkamp N, Ramp U, Geddert H, Schulz WA, Florl AR, Suschek CV, Hassan M, Gabbert HE, Mahotka C.

Eur J Cancer. 2006 Jan;42(2):264-74. Epub 2006 Jan 4.

PMID:
16386893
20.

Ghrelin expression in normal kidney tissue and renal carcinomas.

Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH, Ozercan MR.

Pathol Res Pract. 2009;205(3):165-73. doi: 10.1016/j.prp.2008.10.002. Epub 2008 Dec 2.

PMID:
19054628

Supplemental Content

Support Center